26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
When dealing with a difficult adversary, sage advice suggests that one should consider “killing the...
Read More >
New Jersey’s Wage Theft Act (WTA) significantly enhances employer penalties under the state’s wage...
Read More >
A judge in the U.S. District Court for the Central District of California recently granted a defenda...
Read More >
This month marks the 55th anniversary of the Civil Rights Act of 1964. This monumental legislation, ...
Read More >
Under the District of Columbia’s Universal Paid Leave Amendment Act of 2016 (UPLA), paid family and...
Read More >
The megadeals of 2019 may be off the table for now, but deal activity across healthcare and pharmace...
Read More >